Öz Purpose: The aim of this study is to investigate the role of epidermal growth factor receptor (EGFR) in odontogenic tumors and rare soft tissue tumors. 
INTRODUCTION
Odontogenic tumors and tumor-like lesions represent a heterogenous group ranging from hamartomatous lesions to malign neoplasms. These lesions which are observed considerably rarely originate from epithelial, ectomesenchymal and/or mesenchymal tissues which try to form teeth. Malignant mesenchymal tumors are observed with a rate of 1% among all malignant tumors in humans 1 . These tumors are important, since they are life threatening and prognosis and treatment is different for different subtypes, though they occur rarely. The Epidermal Growth Factor Receptor (HER1/EGFR) is a cell membrane receptor and its intrensic protein has tyrosine kinase activity. EGFR is a member of erbB receptor family. In presence of Epidermal Growth Factor (EGF) or Transforming Growth Factor-a (TGF-a) ligands and with tyrosine kinase activation, HER1/EGFR combines with the other members of this family in such a way as to form hetero or homodimers. Thus, the receptor initiates a signal pathway which also involves RAS and mitogen activated protein kinase (MAPK). This pathway enables the cellular cycle to switch from G1 to S phase by affecting the nuclear proteins including cyclin D1 2, 3 .
Currently, the correlation of EGFR amplification with agressive biological behavior and poor prognosis is well defined4. As a result of this, use of anti-EGFR antibodies affecting the signal pathway targeting EGFR ("targeted cancer treatment") is applied in treatment of different cancer types. However, EGFR has not been investigated in rare tumors of soft tissue and in a large portion of odontogenic tumors and therefore anti-EGFR modalities have not been tried in treatment.
The aim of this study was to investigate the state of EGFR which is a proto-oncogene in the abovementioned tumor groups using both immunohistochemistry and FISH method and contibute to the pathogenesis, prognosis and treatment in these cases.
MATERIAL AND METHOD

Study Population
Twenty eight subjects who were diagnosed in Çukurova University, Medical Faculty, Department of Pathology between 2002 and 2010 were selected for the study. 11 of these subjects had odontogenic tumor and the distribution was as follows: 1 odontogenic fibroma, 2 adenomatoid odontogenic tumors, 1 calcified epithelial odontogenic tumor, 1 compound odontoma, 1 ameloblastic fibroodontoma, 5 ameloblastomas. 17 had rare soft tissue tumor and the distribution was as follows: 4 chordomas, 2 epitheloid hemangioendotheliomas (HE), 1 composite HE; 1 retiform HE, 1 spindle cell hemangioma, 1 glomus tumor, 4 clear cell sarcomas, 3 low grade fibromyxoid sarcomas (LGFMS). The paraffin-embedded blocks and slides were taken out of the archives, reviewed and the most appropriate blocks were selected for immunohistochemistry and FISH methods. EGFR was studied in all subjects using the immunohistochemistry method and FISH method.
Immunohistochemistry
Four micron sections from the blocks selected for application of EGFR primary antibody with immunohistochemistry method were taken to polylysin slides (PLL). They were treeated with dry and heat air for dehydration. They were kept at 0ºC for 5 minutes for adhesion of the tissues. Afterwards, they were treated with dry and heat air again, kept in warm xylene in 56ºC incubator for deparaffinization process for 10 minutes and kept in Three consecutive xylene sets for one minute each. They were kept in 3 distilled water sets for one minute each to remove ethanol. The sections were washed with distilled water after being kept in 3% H₂O₂ solution for 5 minutes to supress the activity of endogenous peroxidase in the tissue. The sections were placed in a reserved plastic chalet which contained citrate (pH 6) and were applied microwave process for 20 minutes at a moderate level. They were let to cool in a reserved way for 45 minutes. Afterwards, they were washed with distilled water and three seperate phosphate buffer solutions (PBS) and EGFR antibody was dropped on the tissues. Following 60-minute incubation, the sections were washed in 3 seperate PBS solutions and were kept for 20 minutes after Biotinylated Link Universal was dropped on top. Following washing with PBS again, 2-3 drops of streptavidin peroxidase solution were dropped and kept for 20 minutes. After the sections were washed with PBS again, they were kept in AEC chromogene for 10 minutes to enable visualization of staining. After staining with PBS opposite staining with haemotoxylene was 318 performed for 5 minutes. Subsequently, the sections were washed with tap water and closed with waterbased material.
Membraneous EGFR was considered specific and scoring was made in two ways 5 
FISH Method
The sections prepared for the FISH method were kept in incubator at 56ºC for one night. On the next day, 15 cc distilled water and 150 microliter 1 mole HCL were added in a seperate slide box for each 5 slides and placed in a beaker filled with water. This beaker was put in an incubator with a temperature of 37ºC. The water bath was adjusted to 80ºC and deparaffinization prewashing solution was placed in a heat-proof reserved chalet. The slides which were taken out of the incubator were kept in three seperate chalets containing xylene for 10 minutes each. The slides were dried at room temperature. The dried slides were kept in the deparaffinization prewashing solution for 30 minutes. At the end of the 30-minute period, the slides were rinsed with distilled water for 10-15 seconds. Just before the slides were placed in the slide box, the enzyme reactive diluted with 150 microliter distilled water was added into the mixture of distilled water and 1 mole HCL inside the slide box which was previously kept in incubator at 37ºC. The slides were kept in enzyme study solution in the slide box in the incubator with a temperature of 37ºC for 15 minutes. At the end of the 15-minute period, the slides were rinsed with distilled water which was at room temperature for 10-15 seconds. The slides were kept in 2XSSC solution at room temperature for three minutes for two times consecutively. The slides which were processed with 70%, 85% and 100% alcohol series for three minutes each were dired. After the deparaffinization stage was completed, the denaturation and probing procedure was started. In evaluation of the cases, all areas with tumor were reviewed and were evaluated as stated in the literature 6 .
-High-level amplification: presence of 10 Figure 1, Figure 2 ), One of these was ameloblastoma ( Figure 3, Figure 4 ), one was retiform HE and one was composite HE. Minimal aberration was found in two patients including one patient with odontogenic fibroma and one patient with ameloblastoma. Disomy was present in 12 patients. Two of these patients had adenomatoid odontogenic tumor, one had calcified odontogenic tumor, one had chordoma, one had epitheloid HE, one had glomus tumor, two had LGFMS and four had clear cell sarcoma (Table 1 ). LGFMS. Low-level amplification was found in three of 11 patients who had EGFR positivity with immunohistochemical method. Minimal aberration was found in two patients, disomy was found in three patients, signal could not be detected in two patients and evaluation could not be made in one patient, since the tissue was shed. Among 17 patients in whom the immunohistochemical method showed a negative result, low-level amplification was found in three, disomy was found in nine and evaluation could not be made in four, since the tissue was shed ( showed EGFR positivity in non-small cell carcinomas of the lung8. EGFR has also been investigated in breast cancer, malign gliomas, salivary gland tumors, gastric carcinomas and bladder tumors [9] [10] [11] [12] [13] . In the literature, EGFR has also been investigated in non-neoplasic/benign lesions. Normal kidney and neoplastic renal tissue, meningiomas, normal epithelium of the cervix and cervical intraepithelial neoplasias, severe dysplasias of the vocal cord, malignant lesions of the thyroid gland, toxic goitre lesions, benign and malignant lesions of the breast, normal superficial epithelium of the ovary, ovarian inclusion cysts and ovary tumors originating from the superficial epithelium have also been investigated in terms of EGFR [14] [15] [16] [17] [18] [19] [20] [21] .
Shresta et al. investigated EGFR expression in odontogenic cysts and tumors and found positivity in odontogenic cysts similar to the cellular membrane in the normal epithelium 22 . Odontogenic tumors did not show expression. In one study conducted by Vered et al., it was reported that EGFR was a receptor which normally had a role in the development of oral mucosa and odontogenesis 23 . Clark et al. evaluated expression of p 53, Ki 67 and EGFR before and after excision in odontogenic keratocysts which have a typical characteristic of demonstrating recurrence 24 . In this study, increased EGFR expression was found in 13 of 16 patients before excision and increased to 15 after excision. This was interpreted as tendency of odontogenic keratocysts to EGFR-related proliferation.
In our study, there was 11 patients with odontogenic tumors and 9 of these patients had a positive stained EGFR by immunohistochemical method. Three of four patients with ameloblastoma whom showed EGFR (++) cytoplasmic staining in more than 50% of the tumor cells and one had EGFR (+) cytoplasmic staining in less than 20% of the tumor cells. Low amplification was found in one of five patients with ameloblastoma with the FISH method and minimal aberration was found in one. Both patients showed EGFR (++) staining immunohistochemically.
EGFR expression has been demonstrated in ameloblastomas in some studies [23] [24] [25] [26] [27] [28] . Among epithelial odontogenic tumors, ameloblastoma is the one which shows strong EGFR expression 29 . It is known that ameloblastomas are radioresistant tumors. Therefore, ameloblastomas which show local agressive behavior are appropriate candidates for anti-EGFR treatment. The preperation phase is very important in determining EGFR expression with immunohistochemical method in ameloblastomas. In our study, one patient with ameloblastoma lacked EGFR staining and no signal could be detected with the FISH method. In one patient with ameloblastoma who was referred from an external center for consultation, EGFR (++) staining immunohistochemically in more than 50% of the tumor cells and no signal was detected with the FISH method. The preperation phase is a multistep process and a change in one of these steps may lead to lack of immunohistochemical response and/or lack of response with the molecular method 25, 27, 28 .
In the study of Oliviera et al. and in some other studies, the response of the cell to the proliferation stimulus increased in cases where EGFR was localized only in the cellular membrane, whereas a slower response occured in cases where EGFR was localized only in the cytoplasm (internalized and inactive) [30] [31] [32] [33] . In our study, (+) cytoplasmic staining was found in less than 10% of the tumor cells in one patient with ameloblastoma. In this patient, no recurrence occured in 9 years. Recurrence was observed in two years in two patients with ameloblastoma who had (++) membraneous staining with EGFR. Based on all these cases, it was concluded that EGFR constituted a very significant step in the pathogenesis in development of odontogenic tumors.
One of the limitations of this study is the odontogenic tumors are highly variable, there are examples from the all 3 WHO benign tumor groups, consequently, the small number of individual cases are not comparable. Further studies are needed for specific subtypes of odontogenic tumors.
EGFR has been studied in soft tissue tumors as well as in many studies and many tumor groups. Yang et al. investigated EGFR overexpression in a heterogeneous group of sarcomas 34 . Swisher et al. reported that EGFR was intesified especially in the sarcomatous areas in uterine sarcomas and adenosarcomas 35 . EGFR overexpression has also been found in synovial sarcoma in different studies 36, 37 .
In the present study, EGFR was found to be positive with immunohistochemical method in two patients with chordoma among 17 cases of soft tissue tumor. 15 patients were negative. Low-level amplification was found with the FISH method in these two chordomas and in another chordoma who was immunohistochemically negative. The remaining patient with chordoma had disomy with FISH. In recent years, many studies showing EGFR expression have been conducted in relation with chordomas 5, 6, [38] [39] [40] [41] [42] [43] . Based on the findings and previous studies, it was concluded that immunohistochemistry alone was not a good marker in demonstrating mutation or copy number 44, 45 . In our study, EGFR overexpression was found by immunohistochemistry and/or FISH method in three of four patients with chordoma. One patient with chordoma was found to be EGFR negative immunohistochemically and disomy by FISH. The role of EGFR in the pathogenesis was emphasized with the findings of our patients with chordoma as stated in the literature.
In our study, there were four patients with clear cell sarcoma and these patients were found to be EGFR negative immunohistochemically and disomy by FISH. In some studies in which mRNA expression profile analysis was made in clear cell sarcoma, erbB3 overexpression was found [46] [47] [48] . In another study, increased erbB3 expression was found in clear cell sarcoma of 8 soft tissues and overexpression was not found in any of them 49 . In the study presented, it can be predicted that EGFR does not play a role in the pathogenesis of clear cell sarcoma with the findings obtained in accordance with the literature.
The composite HE and retiform HE were EGFR negative immunohistochemically and had low-level amplification by FISH in this study. There is no such example in the literature. Our study had a small sample size. Thus, the importance of EGFR in the pathogenesis and treatment in these two tumor groups should be investigated in larger series.
One of limitations of our study is a non-optimal tissue processing for molecular testing. For instance, there were 8 patients three of whom were found to be positive EGFR staining by immunohistochemically and five of them lack EGFR. FISH material was not sufficient in these 8 patients. In two of them, the tissue was shed. One of these patients had ameloblastoma and the sample belonged to 2002 and was exposed to decalcification process. The other patient had epitheloid HE. Signal could not be obtained in the remaining 6 patients. Immunohistochemical EGFR positivity was present with varying rates in two of these patients. In the literature, there are many studies investigating the FISH technique and its limitations. In some of these studies, 1p and 19q probes of different trademarks were evaluated comparatively with PCR and FISH in patients with glioma and it was noted that weak signal was obtained with some probes [50] [51] [52] [53] [54] .
The main disadvantage of the FISH method is nuclear cessation artifacts and hybridization defect55. Sufficient number of cells should be evaluated manually to obtain a statistically significant result. Therefore, it takes considerable time to evaluate and report this method. Aneuploidy and polyploidy signal counting may be confusing 55, 56 .
The FISH technique has three basic phases. Although fixation which is the first phase changes by the material to be used, some of the cases in our study were constituted of paraffine tissues fixed with formaldehyde exposed to decalcification process. Presence of FISH signal in tissues embedded in paraffine is evaluated with much more difficulty compared to conventional cytogenetic materials 57 . The main problems include unsuccessful hybridization, resulting weak binding of probe, excessive probe need, background staining, autoflourescence and dividing in the nucles [58] [59] [60] [61] .
It has been found that the findings obtained by immunohistochemical method and FISH method do not necessarly overlap. Although there are stuides in the literature showing that the FISH method is specific than the immunohistochemical method, trouble in any phase in the preparation period or in the tissue follow-up period makes it difficult to make a healthy evaluation, since this method (FISH) has sensitive steps. Therefore, the tissue to be studied genetically should be prepared under optimal conditions. It has been demonstrated that targeted therapies inhibiting EGFR-mediated pathways may also be beneficial in some soft tissue sarcomas62-65. However, large-scale, multi-center studies should be conducted to develop treatment modalities which would provide clinially significant benefit, since soft tissue saromas are observed rarely.
